Early research (Phase 1)Looking for participantsNCT07224373What this trial is testingAn Open-label Study of AZD0120 in Adults With Multiple SclerosisWho this might be right forMultiple Sclerosis AstraZeneca 24
Early research (Phase 1)Study completedNCT01381354What this trial is testingNutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS)Who this might be right forMultiple Sclerosis University of Iowa 38
Large-scale testing (Phase 3)Active Not RecruitingNCT06141486What this trial is testingEfficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple SclerosisWho this might be right forMultiple Sclerosis Sanofi 943
Not applicableLooking for participantsNCT07355387What this trial is testingHome Based Functional Balance Intervention for Multiple SclerosisWho this might be right forMultiple SclerosisMultiple Sclerosis (MS) - Relapsing-remittingMultiple Sclerosis (MS) Primary Progressive+2 more University of Illinois at Chicago 75
Not applicableUnknownNCT04304027What this trial is testingExercise to Manage Fatigue in Progressive Multiple SclerosisWho this might be right forMultiple Sclerosis Glasgow Caledonian University 45
Testing effectiveness (Phase 2)Study completedNCT02228213What this trial is testingSafety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple SclerosisWho this might be right forSecondary Progressive Multiple Sclerosis Innate Immunotherapeutics 93
Not applicableStudy completedNCT03134573What this trial is testingMedication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot StudyWho this might be right forMultiple Sclerosis Bayer 96
Large-scale testing (Phase 3)Study completedNCT01433497What this trial is testingEfficacy and Safety of Masitinib in the Treatment of Progressive Multiple SclerosisWho this might be right forMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Primary ProgressiveMultiple Sclerosis, Relapse Free AB Science 656
Not applicableEnrolling By InvitationNCT05706220What this trial is testingVisual Processing Speed and Objective Analysis of Ocular Movements in Multiple SclerosisWho this might be right forMultiple SclerosisClinically Isolated SyndromeRelapsing Remitting Multiple Sclerosis+1 more Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA 120
Not applicableLooking for participantsNCT05204459What this trial is testingMS-ResearchBiomarkerSWho this might be right forMultiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+8 more Cedars-Sinai Medical Center 1,000
Early research (Phase 1)Ended earlyNCT01318421What this trial is testingELND002 in Patients With Relapsing Forms of Multiple SclerosisWho this might be right forMultiple Sclerosis Elan Pharmaceuticals 12
Testing effectiveness (Phase 2)Looking for participantsNCT07477639What this trial is testingTreatment of Participants With Primary or Secondary Progressive Multiple SclerosisWho this might be right forPrimary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis (SPMS)Multiple Sclerosis+2 more Tr1X, Inc. 39
Post-approval studies (Phase 4)UnknownNCT04550455What this trial is testingA Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine TabletsWho this might be right forMultiple Sclerosis Keith Edwards, M.D. 30
Not applicableStudy completedNCT06737419What this trial is testingReal World Effectiveness, Persistence, Tolerability, and Safety of Ofatumumab in Clinical PracticeWho this might be right forMultiple Sclerosis Novartis Pharmaceuticals 175
Not applicableEnded earlyNCT02016222What this trial is testingTear Analysis in the Diagnosis of Multiple SclerosisWho this might be right forPrimary Progressive Multiple Sclerosis Lille Catholic University 80
Testing effectiveness (Phase 2)Study completedNCT06894940What this trial is testingRehabilitative Protocols in Progressive Multiple Sclerosis Treated with Anti CD20 Monoclonal AntibodiesWho this might be right forMultiple Sclerosis University of Pavia 82
Not applicableStudy completedNCT01097538What this trial is testingStudy of Alternative Exercise Therapies for Progressive Multiple Sclerosis (MS)Who this might be right forMultiple Sclerosis Hicks, Audrey, Ph.D. 10
Large-scale testing (Phase 3)Study completedNCT03606460What this trial is testingEvaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants With Primary Progressive Multiple Sclerosis (PPMS) and Relapsing Multiple Sclerosis (RMS)Who this might be right forMultiple Sclerosis Genentech, Inc. 141
Large-scale testing (Phase 3)Active Not RecruitingNCT05147220What this trial is testingEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)Who this might be right forRelapsing Multiple Sclerosis Novartis Pharmaceuticals 1,000
Large-scale testing (Phase 3)Study completedNCT01917019What this trial is testingA Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple SclerosisWho this might be right forMultiple Sclerosis, Remittent ProgressiveMultiple Sclerosis, Primary ProgressiveRelapsing-Remitting Multiple Sclerosis+2 more Biogen 101